David Duane House - 02 Oct 2024 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
SVP, Finance, and PFO
Signature
/s/ David D. House
Issuer symbol
ARMP
Transactions as of
02 Oct 2024
Net transactions value
$0
Form type
4
Filing time
03 Oct 2024, 16:15:12 UTC
Previous filing
19 Aug 2024
Next filing
07 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award $0 +75,000 $0.000000 75,000 02 Oct 2024 Common Stock 75,000 $2.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest and become exercisable 25% on August 16th of each of 2025, 2026, 2027, and 2028, in each case subject to continuous service through the applicable vesting date.